Viatris Inc VTRS.OQ reported quarterly adjusted earnings of 62 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 69 cents. The mean expectation of six analysts for the quarter was for earnings of 56 cents per share. Wall Street expected results to range from 53 cents to 58 cents per share.
Revenue fell 5.6% to $3.58 billion from a year ago; analysts expected $3.47 billion.
Viatris Inc's reported EPS for the quarter was breakeven results.
The company reported a quarterly loss of $4.6 million.
Viatris Inc shares had fallen by 2.0% this quarter and lost 29.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.6% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 6 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Viatris Inc is $10.50, about 16.7% above its last closing price of $8.75
This summary was machine generated from LSEG data August 7 at 04:49 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.56 | 0.62 | Beat |
Mar. 31 2025 | 0.49 | 0.50 | Beat |
Dec. 31 2024 | 0.57 | 0.54 | Missed |
Sep. 30 2024 | 0.68 | 0.75 | Beat |